Li X, Jin B, Liu S, Zhu Y, Li N, Zhang Q
Acta Pharmacol Sin. 2025; .
PMID: 39900822
DOI: 10.1038/s41401-024-01460-z.
Hackl A, Weber L
Pediatr Nephrol. 2025; .
PMID: 39856247
DOI: 10.1007/s00467-025-06670-z.
Ahmad S, Christova T, Pye M, Narimatsu M, Song S, Wrana J
Cells. 2025; 14(1.
PMID: 39791757
PMC: 11720052.
DOI: 10.3390/cells14010056.
Bou Malhab L, Schmidt S, Fagotto-Kaufmann C, Pion E, Gadea G, Roux P
Cells. 2024; 13(19.
PMID: 39404389
PMC: 11475522.
DOI: 10.3390/cells13191625.
Yu Y, Cai Y, Yang F, Yang Y, Cui Z, Shi D
Heliyon. 2024; 10(18):e37727.
PMID: 39309965
PMC: 11416558.
DOI: 10.1016/j.heliyon.2024.e37727.
Migrasomes from adipose derived stem cells enrich CXCL12 to recruit stem cells via CXCR4/RhoA for a positive feedback loop mediating soft tissue regeneration.
Chen Y, Li Y, Li B, Hu D, Dong Z, Lu F
J Nanobiotechnology. 2024; 22(1):219.
PMID: 38698419
PMC: 11067256.
DOI: 10.1186/s12951-024-02482-9.
Role of Rho-Associated Kinase in the Pathophysiology of Cerebral Cavernous Malformations.
Ayata C, Kim H, Morrison L, Liao J, Gutierrez J, Lopez-Toledano M
Neurol Genet. 2024; 10(1):e200121.
PMID: 38179414
PMC: 10766084.
DOI: 10.1212/NXG.0000000000200121.
Small-Molecule Probes as Pharmacological Tools for the Bone Morphogenetic Protein Signaling Pathway.
Riege D, Herschel S, Fenkl T, Schade D
ACS Pharmacol Transl Sci. 2023; 6(11):1574-1599.
PMID: 37974621
PMC: 10644459.
DOI: 10.1021/acsptsci.3c00170.
Neuronal membrane proteasome-derived peptides modulate NMDAR-dependent neuronal signaling to promote changes in gene expression.
Turker F, Brennan A, Margolis S
Mol Biol Cell. 2023; 35(1):ar6.
PMID: 37910253
PMC: 10881162.
DOI: 10.1091/mbc.E23-06-0218.
Talin-1 inhibits Smurf1-mediated Stat3 degradation to modulate β-cell proliferation and mass in mice.
Hou X, Chen Y, Zhou B, Tang W, Ding Z, Chen L
Cell Death Dis. 2023; 14(10):709.
PMID: 37903776
PMC: 10616178.
DOI: 10.1038/s41419-023-06235-8.
PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression.
Taghehchian N, Maharati A, Akhlaghipour I, Zangouei A, Moghbeli M
Cancer Cell Int. 2023; 23(1):233.
PMID: 37807067
PMC: 10561470.
DOI: 10.1186/s12935-023-03086-3.
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS.
Yin G, Huang J, Petela J, Jiang H, Zhang Y, Gong S
Signal Transduct Target Ther. 2023; 8(1):212.
PMID: 37221195
PMC: 10205766.
DOI: 10.1038/s41392-023-01441-4.
BAG6 supports stress fiber formation by preventing the ubiquitin-mediated degradation of RhoA.
Miyauchi M, Matsumura R, Kawahara H
Mol Biol Cell. 2023; 34(4):ar34.
PMID: 36884293
PMC: 10092643.
DOI: 10.1091/mbc.E22-08-0355.
Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment.
Hauser N, Hirbawi J, Saban Golub M, Zabit S, Lichtenstein M, Lorberboum-Galski H
Cancers (Basel). 2023; 15(1).
PMID: 36612252
PMC: 9818074.
DOI: 10.3390/cancers15010256.
Smurf1 regulates ameloblast polarization by ubiquitination-mediated degradation of RhoA.
Niu H, Bi F, Zhao W, Xu Y, Han Q, Guo W
Cell Prolif. 2022; 56(4):e13387.
PMID: 36579844
PMC: 10068949.
DOI: 10.1111/cpr.13387.
S-Benproperine, an Active Stereoisomer of Benproperine, Suppresses Cancer Migration and Tumor Metastasis by Targeting ARPC2.
Jang H, Yoon Y, Choi J, Lee Y, Lee S, Cho W
Pharmaceuticals (Basel). 2022; 15(12).
PMID: 36558913
PMC: 9785746.
DOI: 10.3390/ph15121462.
Regulation of Cdc42 protein turnover modulates the filamentous growth MAPK pathway.
Gonzalez B, Cullen P
J Cell Biol. 2022; 221(12).
PMID: 36350310
PMC: 9811999.
DOI: 10.1083/jcb.202112100.
E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration.
Zeng R, Xiong Y, Lin Z, Panayi A, Sun Y, Cao F
Stem Cells Int. 2022; 2022:6948367.
PMID: 36203882
PMC: 9532118.
DOI: 10.1155/2022/6948367.
Activation of RhoC by regulatory ubiquitination is mediated by LNX1 and suppressed by LIS1.
Kholmanskikh S, Singh S, Ross M
Sci Rep. 2022; 12(1):16493.
PMID: 36192543
PMC: 9529947.
DOI: 10.1038/s41598-022-19740-1.
The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer.
Chen X, Jiang L, Zhou Z, Yang B, He Q, Zhu C
Front Pharmacol. 2022; 13:928794.
PMID: 35847032
PMC: 9285105.
DOI: 10.3389/fphar.2022.928794.